4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001140361-22-045712
Options or other derivatives
- Chief Commercial Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lea Darrell Shane Chief Commercial Officer | 2022-11-21 | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | D | ||
Loading xslF345X03/form4.xml…